Chemical Compound

Physostigmine salicylate; (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate; Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI); Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1); Physostigmine salicylate (6CI); Physostigmine, monosalicylate (8CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt) (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt); Salicylic acid, compd. with physostigmine (1:1) (8CI); (-)-Physostigmine salicylate; Eserine salicylate; Isopto Eserine

CAS Registry Number 57-64-7
返回搜索 申请报价
Physostigmine salicylate; (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate; Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI); Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1); Physostigmine salicylate (6CI); Physostigmine, monosalicylate (8CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt) (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt); Salicylic acid, compd. with physostigmine (1:1) (8CI); (-)-Physostigmine salicylate; Eserine salicylate; Isopto Eserine 结构式
Primary record

Physostigmine salicylate; (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate; Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI); Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1); Physostigmine salicylate (6CI); Physostigmine, monosalicylate (8CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt) (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt); Salicylic acid, compd. with physostigmine (1:1) (8CI); (-)-Physostigmine salicylate; Eserine salicylate; Isopto Eserine

库存
5,456 克
纯度
98.2 %
CAS
57-64-7

化合物标识与属性

CAS
57-64-7
PubChem CID
657348
SMILES
C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C.C1=CC=C(C(=C1)C(=O)O)O
Canonical SMILES
CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)c1ccccc1O

名称与同义词

  • Physostigmine salicylate
  • Antilirium
  • Eserine salicylate
  • Isopto Eserine
  • 57-64-7
  • Physostol salicylate
  • Physostigmine (salicylate)
  • Physostigmine monosalicylate
  • Antilirium (TN)
  • Isopto P-ES
  • Physostigmini salicylas
  • ANTICHOLIUM
  • AC1LCWEA
  • Eserine salicylate salt
  • Spectrum_000223
  • Opera_ID_194
  • RefChem:56715
  • 2046ZRO9VU
  • 57-64-7 (salicylate)
  • UNII-2046ZRO9VU
  • PHYSOSTIGMINESALICYLATE
  • (-)-Physostigmine salicylate
  • RCRA waste no. P188
  • MLS000028388
  • CCRIS 3405
  • Physostigmine salicylate [JAN]
  • Physostigmine salicylate CRS
  • Physostigmine salicylate salt
  • SCHEMBL41555
  • KBioSS_000703
  • CHEBI:48883
  • physostigmine; salicyclic acid
  • DivK1c_000339
  • NSC-757275
  • SPECTRUM1500486
  • DTXSID80883232
  • Physostigmine, salicylate (1:1)
  • HZOTZTANVBDFOF-PBCQUBLHSA-N
  • Physostigmine salicylate(1:1)
  • AR-44
  • C22H27N3O5
  • CHEMBL338975
  • orb1310908
  • SCHEMBL29787035
  • C15H21N3O2.C7H6O3
  • EINECS 200-343-8
  • ERK5-2A03
  • HMS501A21
  • HY-B1266R
  • KBio1_000339
  • KBio2_000703
  • KBio2_003271
  • KBio2_005839
  • Physostigmine salicylate [USP:JAN]
  • MFCD00135659
  • NINDS_000339
  • DTXCID501022781
  • HMS1920H12
  • HMS2091P16
  • HMS2235G19
  • Pharmakon1600-01500486
  • BCP25378
  • CID 5992
  • HY-B1266
  • TL-1380
  • Physostigmine salicylate (JAN/USP)
  • 6290AF
  • CCG-39918
  • CID657348
  • EBC-75102
  • EX-A11396
  • NSC757275
  • PHYSOSTIGMINE SALICYLATE [MI]
  • Physostigmine salicylate [USAN:JAN]
  • SMR000058606
  • AKOS037515711
  • Physostigmine (salicylate) (Standard)
  • CID:657348
  • NSC 757275
  • SDCCGMLS-0002925.P003
  • IDI1_000339
  • PHYSOSTIGMINE SALICYLATE [MART.]
  • PHYSOSTIGMINE SALICYLATE [VANDF]
  • NCGC00024464-02
  • PHYSOSTIGMINE SALICYLATE [USP-RS]
  • PHYSOSTIGMINE SALICYLATE [WHO-DD]
  • PHYSOSTIGMINE SALICYLATE [WHO-IP]
  • AC-37462
  • DA-56832
  • Eserine salicylate salt, >=97.0% (N)
  • MS-27151
  • SID:134221904
  • 57-64-7, 57-47-6 [physostigmine]
  • C15-H21-N3-O2.C7-H6-O3
  • CS-0013051
  • FT-0699661
  • NS00078948
  • Salicylic acid, compd. with physostigmine (1:1)
  • PHYSOSTIGMINI SALICYLAS [WHO-IP LATIN]
  • D02418
  • PHYSOSTIGMINE SALICYLATE [EP MONOGRAPH]
  • PHYSOSTIGMINE SALICYLATE [USP MONOGRAPH]
  • A903540
  • C026718
  • SR-01000075341
  • SR-01000075341-3
  • SR-01000075341-5
  • SR-01000075341-7
  • Q27121383
  • Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate)
  • B0084-028331
  • Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl methylcarbamate (1:1)
  • (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate 2-hydroxybenzoate
  • [(3Ar,8bS)-3,4,8b-trimethyl-2,3,3a,4-tetrahydro-1H-pyrrolo[2,3-b]indole-3,4-diium-7-yl] N-methylcarbamate;2-oxidobenzoate
  • Physostigmine salicylate, European Pharmacopoeia (EP) Reference Standard
  • Physostigmine salicylate, United States Pharmacopeia (USP) Reference Standard
  • (3aS,8aR)-1,3a,8-trimethyl-5-(methylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indolium salicylate
  • [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate (2-hydroxybenzoic acid) salt
  • [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate, 2-hydroxybenzoic acid
  • [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate; 2-hydroxybenzoic acid
  • [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid
  • 2-Hydroxybenzoic acid--(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate (1/1)
  • 200-343-8
  • Benzoic acid, 2-hydroxy-, compd with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate ester (1:1)
  • Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl N-methylcarbamate (1:1)
  • Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
  • Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl methylcarbamate ester (1:1)
  • Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate ester (1:1)
  • Benzoic acid, 2-hydroxy-, compound with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
  • Physostigmine salicylate; (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate; Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI); Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1); Physostigmine salicylate (6CI); Physostigmine, monosalicylate (8CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt) (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt); Salicylic acid, compd. with physostigmine (1:1) (8CI); (-)-Physostigmine salicylate; Eserine salicylate; Isopto Eserine